Assyro AI

Orange Book product · Brand (NDA)

PROMACTA KIT

ELTROMBOPAG OLAMINE

Brand (NDA)NDA 207027TE ABRX NOVARTIS

At a glance

Aug 24, 2015

Approved

Brand (NDA)

Application

AB

TE code

5

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 24, 2015

    11 yr ago

  2. Patent 7547719 expires

    Listed drug substance patent expiration.

    Jul 13, 2025

    11 mo ago

  3. Patent 7547719 expires

    Listed drug substance patent expiration.

    Jul 13, 2025

    11 mo ago

  4. Patent 7547719 expires

    Listed drug substance patent expiration.

    Jul 13, 2025

    11 mo ago

  5. Patent 7547719 expires

    Listed drug substance patent expiration.

    Jul 13, 2025

    11 mo ago

  6. Patent 7547719*PED expires

    Listed listed patent expiration.

    Jan 13, 2026

    5 mo ago

  7. Today

Pharmaceutical detail

Active ingredient

ELTROMBOPAG OLAMINE

Strength

EQ 25MG ACID/PACKET

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

AB

Application

NDA 207027

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7547719Jul 13, 202511 mo ago
SubstanceProductU-1575
7547719Jul 13, 202511 mo ago
SubstanceProductU-1736
7547719Jul 13, 202511 mo ago
SubstanceProductU-2452
7547719Jul 13, 202511 mo ago
SubstanceProductU-1306
7547719*PEDJan 13, 20265 mo ago
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.